Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Schrodinger, Inc. (SDGR) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Schrodinger, Inc. (SDGR), most recent 12 months reported: revenue $259.04M, net loss $54.34M, free cash flow -$130.27M. Latest balance sheet on file: liquid cash $413.74M. From SEC filings. Others in Pharmaceutical Preparations: LIGAND PHARMACEUTICALS INCORPORATED · Protagonist Therapeutics, Inc · RIGEL PHARMACEUTICALS, INC. · Harrow, Inc. · Syndax Pharmaceuticals, Inc. · RHYTHM PHARMACEUTICALS, INC. · PHATHOM PHARMACEUTICALS, INC. · ANAPTYSBIO, INC.

Stock screener

Watchlist